Microbiota ocular y formas de disbiosis

La microbiota ocular juega un papel importante en el equilibrio del ecosistema ocular y en la protección contra la infección por patógenos externos.

Sin embargo, la alteración de la microbiota ocular, conocida como disbiosis, puede estar asociada a varias enfermedades oculares, como conjuntivitis, queratitis, uveítis y síndrome del ojo seco.

La disbiosis de la microbiota ocular puede ser causada por varios factores, incluido el uso de antibióticos, la cirugía ocular, la enfermedad diabética, la quimioterapia y el uso de lentes de contacto.

La disbiosis puede provocar una disminución de la diversidad microbiana y un aumento de la presencia de ciertos microorganismos, como los estafilococos.

La disbiosis de la microbiota ocular puede causar inflamación ocular y reducir la resistencia del ojo a las infecciones. Además, puede alterar la composición de la película lagrimal, aumentando la evaporación de las lágrima y provocar un síndrome de ojo seco.

La disbiosis de la microbiota ocular se puede tratar desde distintos enfoques terapéuticos, incluida la administración de probióticos, el uso de colirios antibióticos específicos, y la terapia de luz pulsada.

La elección del tratamiento depende de la causa subyacente de la disbiosis y de la gravedad de la patología ocular asociada.


Bibliografía:
Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol. 2012 Jun;129(6):434-40.
Agrawal R, Balne PK. Eye infections and use of contact lenses. Rev Environ Health. 2016 Jun 1;31(2):225-8.
Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005 Mar 25;307(5717):1915-20.
Behlau I, Gilmore MS. Microbial biofilms in ophthalmology and infectious disease. Arch Ophthalmol. 2008 Sep;126(9):1572-81.
Belda-Ferre P, Alcaraz LD, Cabrera-Rubio R, Romero H, Simón-Soro Á, Pignatelli M, et al. The oral metagenome in health and disease. ISME J. 2012 Jul;6(1):46-56.
Calderón-Santiago M, García-Sánchez S, Almagro-Moltó M, López-Sánchez J, Pérez-Ortega S, Ruiz-Ruiz C, et al. Ocular surface microbial alterations in ocular rosacea patients. Int J Med Microbiol. 2015 Oct;305(7):816-23.
Cogen AL, Nizet V, Gallo RL. Skin microbiota: a source of disease or defence? Br J Dermatol. 2008 May;158(5):442-55.
de Sousa LB, Teixeira F, Silva MA, Sousa-Rodrigues CF, Correia-Silva J, Sampaio-Maia B. Microbial succession and flavor production in the fermented dairy beverage kefir. Microorganisms. 2020 Jun 6;8(6):871.
DePaiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, et al. Altered tear biomarkers in dry eye disease: a systemic review and meta-analysis. Sci Rep. 2017 May 5;7(1):507.
Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, et al. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci. 2011 Mar 15;52(3):5408-13.
Dong Q, Brulc JM, Iovieno A, Ziemer CJ, Toh E, Hisamatsu T, et al. Comparative analysis of the microbial communities in the drinking water of two different bottled water brands. PLoS One. 2011;6(10):e26789.
Dong Q, Brulc JM, Iovieno A, Ziemer CJ, Toh E, Lee J, et al. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci. 2011 Mar 15;52(3):5408-13.
Flores GE, Henley JB, Fierer N. A direct PCR approach to accelerate analyses of human-associated microbial communities. PLoS One. 2012;7(6):e37603.
González-Márquez H, Milián-Suazo F, Valdez-García J, Valdez-González R, Santacruz-Valdez C, Flores-Villaseñor H, et al. Comparison of the conjunctival microbiota in HIV-positive and HIV-negative patients in Mexico. PLoS One. 2017 May 31;12(5):e0178220.
Huang Y, Yang B, Li W. Defining the normal core microbiome of conjunctival microbial communities. Clin Microbiol Infect. 2016 Apr;22(4):643.e7-12.
Kugadas A, Christiansen SH, Sankaranarayanan S, Surana NK, Gauguet S, Kunz R, et al. Impact of microbiota on resistance to ocular pseudomonas aeruginosa-induced keratitis. PLoS Pathog. 2016 Nov 23;12(11):e1005855.
Lelli D, Pedrotti E, Bonetto E, Rama P. Microbiota-gut-eye axis in ophthalmic diseases: moving beyond ocular surface infections. J Clin Med. 2021 Feb 4;10(4):624.
Liu Y, Chen X, Qin S, Zhang S, Wu S, Yang C, et al. Alterations in the ocular surface microbiome in pterygium. Int J Ophthalmol. 2020 Mar 18;13(3):358-63.
Ozkan J, Nielsen S, Diez-Vives C, Coroneo M, Thomas T, Willcox MD. Temporal stability and composition of the ocular surface microbiome. Sci Rep. 2017 May 23;7(1):9880. Ozkan J, Willcox MDP. The ocular microbiome: molecular characterisation, function and disease. Ophthalmic Physiol Opt. 2019 Mar;39(2):123-36.
Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, et al. Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci. 2011 Mar 3;52(3):5408-13.
Tam BM, Siu AW, Guzman-Aranguez A, Amigo JD, Vargas-Mendoza CF, Molina-Martínez IT, et al. Topical application of a gut-bacterium-derived molecule, FeCl3-Producing Escherichia coli, protects the ocular surface from Pseudomonas aeruginosa infection. mBio. 2020 Feb 25;11(1):e03210-19.
Cavuoto KM, Banerjee S, Galor A. Relationship between the microbiome and ocular health. Ocul Surf. 2016 Jan;14(1):1-14.
Dong Q, Brulc JM, Iovieno A, Bates B, Garoutte A, Miller D, et al. Comparative analysis of the human conjunctival and meibomian gland microbiome in health and disease. Transl Vis Sci Technol. 2018 Nov 6;7(6):11.
Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010 Jul;29(4):312-34.
de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, et al. Altered mucosal microbiome diversity and disease severity in Sjögren syndrome. Sci Rep. 2016 Nov 22;6:23561.
Doan T, Akileswaran L, Andersen D, Johnson B, Ko N, Shrestha A, et al. Paucibacterial microbiome and resident DNA virome of the healthy conjunctiva. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5116-26.
Huang Y, Yang B, Li W. Defining the normal core microbiome of conjunctival microbial communities. Clin Microbiol Infect. 2016 Apr;22(4):643.e7-12.
Li Z, Liu Z, Li M, Li X, Fang W. The ocular surface microbiome in vernal keratoconjunctivitis. Ocul Surf. 2021 Apr;19:235-42.
McElvania TeKippe E, Allen MS, Yerges-Armstrong LM, Sullivan SA, Falkowski NR, Kabbani D, et al. In vitro assessment of biofilm formation on contact lenses and the ocular surface. JAMA Ophthalmol. 2019 Oct 1;137(10):1135-41.
Moyo S, Motaung T, Mabayoje V, Ogunro B, Ncwadi N, Nkosi D, et al. Ocular microbiome of South African HIV-positive patients with severe immune suppression. Ocul Surf. 2020 Oct;18(4):710-8.


FAQs relacionados
🇬🇧
🇮🇹
🇪🇸
Eyemetagenomics Ltd
71-75 Shelton Street, Covent Garden
London WC2H 9JQ, ENGLAND
LUCY does not claim to diagnose, treat, cure, or prevent any disease. The information on the LUCY website is provided for informational purposes only and with the understanding that LUCY is not engaged in rendering medical advice or recommendations. You should not rely on any information on the website to diagnose or treat a health problem or condition or replace consultations with qualified health care professionals to meet your individual needs. Always check with your doctor for answers to your personal medical questions.

Copyright © 2024 Eyemetagenomics Ltd. All rights reserved.
Cookie Policy